Method for prongf assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of prongf
AssigneesUniversite des Sciences et Technologies de Lille, Biomerieux
InventorsGeneviève CHOQUET-KASTYLEVSKY, Yohann DEMONT, Hubert HONDERMARCK
Life of this patent
Estimating the term…
Abstract
A ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer.
Claims10
A method for treatment of a patient suffering from cancer, comprising administering a therapeutically effective amount of a ProNGF inhibitor to said patient.
A method of blocking cancerous cell migration, comprising administering an effective amount of a ProNGF inhibitor to a person, thereby blocking migration of cancer cells.
A pharmaceutical composition, comprising, as an active ingredient, at least one ProNGF inhibitor in combination with a pharmaceutually acceptable excipient.
Dependencies are inferred from the claim text.